Literature DB >> 23756178

Meta-analysis confirms a functional polymorphism (5-HTTLPR) in the serotonin transporter gene conferring risk of bipolar disorder in European populations.

Hong-Yan Jiang1, Fei Qiao, Xiu-Feng Xu, Yuan Yang, Yan Bai, Ling-Ling Jiang.   

Abstract

The serotonin transporter (5-HTT) is a candidate risk gene for bipolar disorder, and a functional polymorphism of 44-bp insertion/deletion (5-HTTLPR) located in the promoter region of this gene has been investigated for the association with the illness extensively among worldwide populations, but overall results were inconsistent and its role in the disorder remains unclear. The present study attempts to find its potential association with bipolar disorder using meta-analyzes that maximize the statistical power. We applied meta-analysis techniques by combining all available case-control studies of 5-HTTLPR and bipolar disorder in samples of European ancestry (with a total of 3778 cases and 4997 controls), and we assessed the evidence for allelic associations, heterogeneity among different studies, influence of each single study, and potential publication bias. The short allele (S allele) of 5-HTTLPR showed a significant association with bipolar disorder in our meta-analysis (odds ratio=1.10, p-value=0.005), suggesting it is likely a risk polymorphism for the illness, and the observed OR is consistent with other susceptibility loci identified through recent large-scale genetic association studies on bipolar disorder, which could be regarded simply as a small but detectable effects.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  5-HTTLPR; Association; Bipolar disorder; Meta-analysis; Serotonin transporter gene

Mesh:

Substances:

Year:  2013        PMID: 23756178     DOI: 10.1016/j.neulet.2013.05.065

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  The association between the 5-HTTLPR and neural correlates of fear conditioning and connectivity.

Authors:  Tim Klucken; Jan Schweckendiek; Carlo Blecker; Bertram Walter; Yvonne Kuepper; Juergen Hennig; Rudolf Stark
Journal:  Soc Cogn Affect Neurosci       Date:  2014-08-19       Impact factor: 3.436

Review 2.  Revisiting tandem repeats in psychiatric disorders from perspectives of genetics, physiology, and brain evolution.

Authors:  Xiao Xiao; Chu-Yi Zhang; Zhuohua Zhang; Zhonghua Hu; Ming Li; Tao Li
Journal:  Mol Psychiatry       Date:  2021-10-14       Impact factor: 15.992

3.  Association of Anxiety Symptoms in Offspring of Bipolar Parents with Serotonin Transporter-Linked Polymorphic Region (5-HTTLPR) Genotype.

Authors:  Min-Hyeon Park; Erica Sanders; Meghan Howe; Manpreet Singh; Joachim Hallmayer; Eunjoo Kim; Kiki Chang
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-07-28       Impact factor: 2.576

Review 4.  The genetics of early-onset bipolar disorder: A systematic review.

Authors:  Kevin P Kennedy; Kathryn R Cullen; Colin G DeYoung; Bonnie Klimes-Dougan
Journal:  J Affect Disord       Date:  2015-05-15       Impact factor: 4.839

5.  Maintenance of Chronic Fatigue Syndrome (CFS) in Young CFS Patients Is Associated with the 5-HTTLPR and SNP rs25531 A > G Genotype.

Authors:  Benedicte Meyer; Chinh Bkrong Thuy Nguyen; Aurora Moen; Even Fagermoen; Dag Sulheim; Hilde Nilsen; Vegard Bruun Wyller; Johannes Gjerstad
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

6.  The role of 5-HTTLPR in autism spectrum disorder: New evidence and a meta-analysis of this polymorphism in Latin American population with psychiatric disorders.

Authors:  D L Nuñez-Rios; R Chaskel; A Lopez; L Galeano; M C Lattig
Journal:  PLoS One       Date:  2020-07-02       Impact factor: 3.240

7.  Childhood adversities and 5-HTTLPR polymorphism as risk factors of substance use disorders: retrospective case-control study in Murcia (Spain).

Authors:  Fernando Navarro-Mateu; Mari Paz Quesada; Teresa Escámez; Mª José Alcaráz; Catherine Seiquer de la Peña; Diego Salmerón; José María Huerta; Gemma Vilagut; Maria Dolores Chirlaque; Carmen Navarro; Mathilde Husky; Ronald C Kessler; Jordi Alonso; Salvador Martínez
Journal:  BMJ Open       Date:  2019-09-04       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.